Facebook
X
LinkedIn
ForwardCrystal Clear Gout Care: Dual Perspectives and Precision Strategies for Today’s Patients – it’s Not “Just Gout”!
Gout is the most prevalent inflammatory arthritis in adults – yet it remains consistently undertreated and poorly controlled in routine practice. This high-impact virtual summit delivers dual perspectives from a rheumatologist and a nephrologist on evidence-based updates and practical strategies to optimize diagnosis, individualize therapy, and improve management of patients with gout, including individuals with chronic kidney disease.
Target Audience
This activity is designed for an audience of US-based rheumatology prescribing HCPs – including MDs, DOs, NPs, and PAs. Since AWIR’s Summits and educational activities are also accessed by global HCPs, the secondary target audience includes ex-US rheumatology HCPs.
Learning Objectives
- Describe the variable onset, progression, and presentation of gout across patient populations, including individuals with chronic kidney disease (CKD)
- Apply evidence-based guidance for the assessment, diagnosis, treatment, and management of gout, with consideration of renal impairment and other comorbidities
- Differentiate existing and emerging treatment options for gout based on mechanisms of action, efficacy and safety data, patient factors, and therapeutic goals
- Integrate current evidence, guideline recommendations, and patient-specific factors to individualize care plans for patients with gout
- Assess common comorbidities associated with gout and analyze the potential role of urate-driven inflammation in contributing to their development and progression
Commercial Support
There is no commercial support for this activity.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Richard Johnson, Board Certified in Medicine and Nephrologu
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Association of Women in Rheumatology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
Physician Associates and Nurse Practitioners
Physician Associates and Nurse Practitioners can claim AMA PRA Category I Credit™, if appropriate, from organizations accredited by ACCME.
Available Credit
- 1.50 ABIM Medical Knowledge
- 1.50 ABP Lifelong Learning & Self-Assessment
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance